ASPEYA
Live / Registered — Registered (as of 06 Jan 2026)
What this means for you
Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98764745
- Registration number
- 8091361
- Mark type
- Stylized text
- Filed
- 23 Sept 2024
- Published for opposition
- 18 Nov 2025
- Registered
- 06 Jan 2026
- Attorney of record
- Tamar Niv Bessinger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations,anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; nutraceuticals for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; vitamins and dietary supplements; pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions; pharmaceutical preparations for treatment of a wide variety of diseases and conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; nicotine chewing gum for use as an aid to stop smoking
- Class 010 — Medical apparatus: Medical devices for use for inhalation of pharmaceutical preparations, sold empty; medical devices for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers for therapeutic purposes, sold empty; dry powder inhalers (DPI) for therapeutic purposes, sold empty; nebulizer for medical purposes; pressurized metered-dose inhalers (pMDI) for therapeutic purposes, sold empty
- Class 042 — Scientific and technological services: Medical research services; scientific research services in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical drug development services; formulation, research, and development of inhaled therapeutics; formulation, research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems
- Class 044 — Medical, beauty and agricultural services: Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals
Owner
- ASPEYA SWITZERLAND SA, LAUSANNE, CH
- ASPEYA SWITZERLAND SA, LAUSANNE, CH
- ASPEYA SWITZERLAND SA, LAUSANNE, CH
- Vectura Fertin Pharma Switzerland S.A., Lausanne, CH
Prosecution history
- 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 29 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 29 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Mar 2025 — NON-FINAL ACTION E-MAILED
- 29 Mar 2025 — NON-FINAL ACTION WRITTEN
- 29 Mar 2025 — ASSIGNED TO EXAMINER